JP2022525302A5 - - Google Patents

Info

Publication number
JP2022525302A5
JP2022525302A5 JP2021554695A JP2021554695A JP2022525302A5 JP 2022525302 A5 JP2022525302 A5 JP 2022525302A5 JP 2021554695 A JP2021554695 A JP 2021554695A JP 2021554695 A JP2021554695 A JP 2021554695A JP 2022525302 A5 JP2022525302 A5 JP 2022525302A5
Authority
JP
Japan
Prior art keywords
cedna vector
prior
itrs
vector according
adjacent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021554695A
Other languages
English (en)
Japanese (ja)
Other versions
JP7583732B2 (ja
JP2022525302A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/022595 external-priority patent/WO2020186150A2/en
Publication of JP2022525302A publication Critical patent/JP2022525302A/ja
Publication of JP2022525302A5 publication Critical patent/JP2022525302A5/ja
Priority to JP2024193194A priority Critical patent/JP2025016685A/ja
Application granted granted Critical
Publication of JP7583732B2 publication Critical patent/JP7583732B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021554695A 2019-03-13 2020-03-13 フェニルアラニンヒドロキシラーゼ(pah)治療薬を発現するための非ウイルス性dnaベクターおよびその使用 Active JP7583732B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024193194A JP2025016685A (ja) 2019-03-13 2024-11-01 フェニルアラニンヒドロキシラーゼ(pah)治療薬を発現するための非ウイルス性dnaベクターおよびその使用

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201962817771P 2019-03-13 2019-03-13
US62/817,771 2019-03-13
US201962857514P 2019-06-05 2019-06-05
US62/857,514 2019-06-05
PCT/US2020/022595 WO2020186150A2 (en) 2019-03-13 2020-03-13 Non-viral dna vectors and uses thereof for expressing phenylalanine hydroxylase (pah) therapeutics

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024193194A Division JP2025016685A (ja) 2019-03-13 2024-11-01 フェニルアラニンヒドロキシラーゼ(pah)治療薬を発現するための非ウイルス性dnaベクターおよびその使用

Publications (3)

Publication Number Publication Date
JP2022525302A JP2022525302A (ja) 2022-05-12
JP2022525302A5 true JP2022525302A5 (cg-RX-API-DMAC7.html) 2023-03-22
JP7583732B2 JP7583732B2 (ja) 2024-11-14

Family

ID=72426457

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021554695A Active JP7583732B2 (ja) 2019-03-13 2020-03-13 フェニルアラニンヒドロキシラーゼ(pah)治療薬を発現するための非ウイルス性dnaベクターおよびその使用
JP2024193194A Pending JP2025016685A (ja) 2019-03-13 2024-11-01 フェニルアラニンヒドロキシラーゼ(pah)治療薬を発現するための非ウイルス性dnaベクターおよびその使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024193194A Pending JP2025016685A (ja) 2019-03-13 2024-11-01 フェニルアラニンヒドロキシラーゼ(pah)治療薬を発現するための非ウイルス性dnaベクターおよびその使用

Country Status (12)

Country Link
US (1) US12415002B2 (cg-RX-API-DMAC7.html)
EP (1) EP3938515A4 (cg-RX-API-DMAC7.html)
JP (2) JP7583732B2 (cg-RX-API-DMAC7.html)
KR (1) KR20210149702A (cg-RX-API-DMAC7.html)
CN (1) CN113874508A (cg-RX-API-DMAC7.html)
AU (1) AU2020235121A1 (cg-RX-API-DMAC7.html)
BR (1) BR112021017852A2 (cg-RX-API-DMAC7.html)
CA (1) CA3133330A1 (cg-RX-API-DMAC7.html)
IL (1) IL286283A (cg-RX-API-DMAC7.html)
MX (1) MX2021011037A (cg-RX-API-DMAC7.html)
SG (1) SG11202109830TA (cg-RX-API-DMAC7.html)
WO (1) WO2020186150A2 (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021252952A1 (en) * 2020-06-11 2021-12-16 Sangamo Therapeutics, Inc. Methods and compositions for expressing phenylalanine hydroxylase
MX2023001109A (es) 2020-07-27 2023-04-24 Anjarium Biosciences Ag Composiciones de moleculas de adn, metodos para elaborar las mismas, y metodos de usos de las mismas.
MX2023003019A (es) * 2020-09-16 2023-05-08 Generation Bio Co Vectores de adn de extremo cerrado y usos de estos para expresar fenilalanina hidroxilasa (pah).
GB202014751D0 (en) * 2020-09-18 2020-11-04 Lightbio Ltd Targeting vector
KR20230079172A (ko) 2020-10-01 2023-06-05 젠자임 코포레이션 간-유도 유전자 대체 요법에 의한 pku의 치료를 위한 인간 pah 발현 카세트
CN115772503B (zh) * 2022-08-16 2023-10-17 广东省南山医药创新研究院 一种表达pah的基因修饰细胞药物及其制备方法与应用
CN121532216A (zh) * 2023-04-18 2026-02-13 赛仁生物技术公司 腺相关病毒载体组合物和使用方法
CN116656740A (zh) * 2023-05-30 2023-08-29 浙江大学 一种腺相关病毒基因治疗载体及其在制备治疗苯丙酮尿症的药物中的应用
CN119876192B (zh) * 2024-07-02 2025-11-07 浙江大学滨江研究院 用于治疗苯丙酮尿症的多核苷酸

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101511373B (zh) * 2006-06-19 2015-12-09 阿斯克肋匹奥生物制药公司 用于基因治疗的修饰的因子ⅷ和因子ⅸ基因和载体
EP2500434A1 (en) 2011-03-12 2012-09-19 Association Institut de Myologie Capsid-free AAV vectors, compositions, and methods for vector production and gene delivery
IL261524B2 (en) 2016-03-03 2023-10-01 Univ Massachusetts End-capped linear double-stranded DNA for non-viral gene transfer
EP3562494A4 (en) * 2016-12-30 2020-08-19 The Trustees Of The University Of Pennsylvania GENE THERAPY FOR THE TREATMENT OF PHENYLKETONURIS
WO2018167621A1 (en) * 2017-03-16 2018-09-20 Pfizer Inc. Tyrosine prototrophy
US11820999B2 (en) * 2017-04-03 2023-11-21 American Gene Technologies International Inc. Compositions and methods for treating phenylketonuria
EP3630200A4 (en) * 2017-05-31 2021-02-24 Arcturus Therapeutics, Inc. THERAPEUTICS FOR PHENYLKETONURIA
MX2020001593A (es) 2017-08-09 2020-07-13 Bioverativ Therapeutics Inc Moleculas de acido nucleico y usos de las mismas.

Similar Documents

Publication Publication Date Title
JP2022524434A5 (cg-RX-API-DMAC7.html)
JP2024009857A5 (cg-RX-API-DMAC7.html)
JP2022549380A5 (cg-RX-API-DMAC7.html)
JP2020533959A5 (cg-RX-API-DMAC7.html)
JP2020532981A5 (cg-RX-API-DMAC7.html)
JP2022508182A5 (cg-RX-API-DMAC7.html)
JP2019116492A5 (cg-RX-API-DMAC7.html)
JP2020519284A5 (cg-RX-API-DMAC7.html)
US20240376498A1 (en) Transgene cassettes, aav vectors and aav viral vectors for the expression of human codon-optimized slc6a1
JP2023520763A5 (cg-RX-API-DMAC7.html)
JP2021534814A5 (cg-RX-API-DMAC7.html)
JP2023520764A5 (cg-RX-API-DMAC7.html)
JP2022551744A5 (cg-RX-API-DMAC7.html)
JP2017529395A5 (cg-RX-API-DMAC7.html)
US20240269161A1 (en) Methods and compositions for tau reduction gene therapy
JP2023537358A5 (cg-RX-API-DMAC7.html)
JP2023059858A5 (cg-RX-API-DMAC7.html)
JP2021534766A5 (cg-RX-API-DMAC7.html)
JP2023541443A5 (cg-RX-API-DMAC7.html)
CN120548368A (zh) 用于正确包装重复元件的腺相关病毒载体
JP2023542131A5 (cg-RX-API-DMAC7.html)
JP2025513785A5 (cg-RX-API-DMAC7.html)
JP2023542132A5 (cg-RX-API-DMAC7.html)
JP2022527126A5 (cg-RX-API-DMAC7.html)
US20260131024A1 (en) Gene therapy for prader willi syndrome